Virpax Pharmaceuticals Inc (VRPX)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current VRPX market cap is 2.32M. The company's latest EPS is USD -3.1079 and P/E is -0.16.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.24M | -6.12M | -4.68M | -3.3M | -3.46M |
| Net Income | -3.11M | -6M | -4.56M | -3.22M | -3.45M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.18M | -4.2M | -12.03M | -21.85M | -15.69M |
| Net Income | -3.31M | -4.34M | -12.06M | -21.65M | -15.19M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 15.95M | 13.04M | 9.63M | 3.13M | 2.59M |
| Total Liabilities | 3.65M | 6.53M | 7.69M | 4.34M | 5.39M |
| Total Equity | 12.3M | 6.51M | 1.93M | -1.21M | -2.79M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 47k | 465k | 39.57M | 19.67M | 9.63M |
| Total Liabilities | 2.78M | 4.68M | 2.09M | 3.1M | 7.69M |
| Total Equity | -2.73M | -4.22M | 37.49M | 16.58M | 1.93M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -4.19M | -6.84M | -9.85M | -7.73M | -9.37M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | 453k | 2.1M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1.13M | -1.39M | -14.54M | -17.85M | -9.85M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 1.13M | 1.4M | 54.35M | N/A | N/A |
| Market Cap | 2.32M |
| Price to Earnings Ratio | -0.16 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.26 |
| Price to Book Ratio | 1.24 |
| Dividend Yield | - |
| Shares Outstanding | 4.89M |
| Average Volume (1 week) | 112.75k |
| Average Volume (1 Month) | 65.52k |
| 52 Week Change | -94.11% |
| 52 Week High | 8.997 |
| 52 Week Low | 0.4603 |
| Spread (Intraday) | 0.02 (3.44%) |
| Company Name | Virpax Pharmaceuticals Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.virpaxpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
